High-purity research and clinical-grade API formulations manufactured under strict cGMP protocol standards for global research institutes and pharmaceutical brands.
Selank is a synthetic heptapeptide derivative of the human immunomodulatory peptide Tuftsin, modified engineered with a Pro-Gly-Pro sequence attached to its C-terminus to enhance enzymatic stability and bio-availability. Structurally recognized as Thr-Lys-Pro-Arg-Pro-Gly-Pro (CAS Registry No: 129954-34-3), Selank 10mg represents a cornerstone in neuropharmacological peptide engineering. As a premier OEM Selank 10mg Manufacturer, Gentolex utilizes state-of-the-art automated Solid-Phase Peptide Synthesis (SPPS) and Liquid-Phase Peptide Synthesis (LPPS) hybrid workflows to produce stable, highly purified, and batch-consistent lyophilized vials engineered to meet international clinical, preclinical, and commercial grade specifications.
Technical Specification Standard: Gentolex OEM Selank 10mg final drug product guarantees HPLC chemical purity exceeding 99.0%, single impurity thresholds maintained strictly under 0.5%, endotoxin concentration below 0.5 EU/mg, and zero detectable residual solvents per ICH Q3C regulatory guidelines.
Understanding the molecular integrity of Selank is paramount for scalable contract manufacturing and contract development. The addition of the tripeptide sequence Pro-Gly-Pro prevents rapid degradation by serum peptidases, extending the peptide half-life significantly compared to native Tuftsin.
| Analytical Metric | Specification Target | Testing Methodology / Instrumentation |
|---|---|---|
| Chemical Name | L-Threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolyl-glycyl-L-proline | IUPAC Nomenclature Validation |
| Molecular Formula & Mass | C33H57N11O9 | 751.9 g/mol | High-Resolution ESI-MS (Electrospray Mass Spectrometry) |
| Chromatographic Purity | ≥ 99.0% (Area Percent) | Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) |
| Physical State & Appearance | White to Off-White Lyophilized Cake/Powder | Visual / Reconstitution Clarity Inspection |
| Bacterial Endotoxins | < 0.5 EU/mg | Kinetic Chromogenic LAL (Limulus Amebocyte Lysate) Test |
| Counterion Content | Acetate (typically 5% - 12%) | Ion Chromatography (IC) / HPLC |
| Moisture Content (Karl Fischer) | ≤ 5.0% | Coulometric Karl Fischer Titration |
As research into neuroactive peptides expands globally, Selank 10mg is utilized across a wide variety of localized biological models and modern therapeutic formulation frameworks:
Our state-of-the-art facilities offer flexible, scalable, and cost-effective turnkey solutions for raw API procurement, custom sequence assembly, and full product line establishment.
An overall factory construction footprint of 250,000 square meters under international regulatory standards. Delivering scalable, high-yield chemistry solutions designed to lower cost-per-gram while maintaining exceptional batch purity.
Gentolex offers an extensive catalog of peptide APIs and active intermediates for preclinical drug development and global commercial deployment. Full DMF documentation, CoAs, HPLC/MS profiles, and ISO certifications are included.
For strategic partner clients seeking to streamline supply chain complexity, we provide end-to-end custom OEM/ODM procurement services backed by China's comprehensive raw material industrial network.
The manufacturing landscape for synthetic peptides is undergoing a shift toward high-throughput, green, and micro-continuous flow processes. Gentolex's technical roadmap for Selank 10mg and related neuroactive peptides targets continuous optimization across four key manufacturing pillars:
Integrating thermal activation directly into solid-phase peptide synthesis step cycles reduces coupling times from hours to minutes. This minimizes steric hindrance issues along the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, suppressing beta-sheet aggregation during chain elongation.
Transitioning from traditional hazardous solvents (e.g., DMF, NMP) toward sustainable green alternatives like 2-Methyltetrahydrofuran (2-MeTHF) and dimethyl carbonate. This reduces environmental burden while complying with modern EU REACH directives.
Utilizing high-pressure, large-diameter reverse-phase chromatography columns coupled with continuous multi-column solvent extraction (MCSGP) systems. Achieves isolated yields >90% while guaranteeing strict batch purity above 99.0%.
China has emerged as the global leader in peptide raw material synthesis and contract manufacturing services. Partnering with Gentolex as your OEM Selank 10mg manufacturer grants structural advantages that protect brand margin and secure supply chain integrity:
Navigating the global bio-pharmaceutical sector requires strict adherence to international standardizations. Regulatory demands for analytical transparency have increased significantly. As a global exporter serving clients in over 10 countries (including established representative networks in Mexico and South Africa), Gentolex provides full compliance packages:
Every commercial batch of OEM Selank 10mg is delivered with extensive validation documentation, including High-Performance Liquid Chromatography (HPLC) chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, Certificate of Analysis (CoA), and Material Safety Data Sheets (MSDS). Furthermore, our stability testing rooms conduct real-time and accelerated shelf-life studies according to standard International Council for Harmonisation (ICH) conditions (25°C/60% RH and 40°C/75% RH).
Gentolex's mission is to build robust global bridges connecting pharmaceutical organizations, research entities, and bio-tech brands with superior contract manufacturing services and fully guaranteed chemical products. To date, Gentolex Group has established active client partnerships across more than 10 countries, featuring physical representative operations in strategic regional hubs such as Mexico and South Africa.
Our core business focuses on supplying premium synthetic peptide APIs, highly customized sequence peptides, FDF license-out solutions, end-to-end technical consultation, laboratory setup, and centralized sourcing supply chain optimization.
Stay informed with technical whitepapers, analytical breakdowns, and manufacturing insights published directly by our peptide synthesis specialists.
Detailed analysis of Selank Acetate API, a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from endogenous Tuftsin. Explores chemical stability, peptide purification, and global supply logistics.
Read Research Report →
An in-depth whitepaper examining Thymosin Beta-4 peptide manufacturing standards, cell migration research applications, structural integrity assays, and custom cGMP OEM options.
Read Research Report →
Technical overview of BPC-157 synthetic pentadecapeptide synthesis pathways, tissue repair pathway investigations, gastrointestinal biological protection mechanisms, and lyophilization setups.
Read Research Report →
Investigating Semax, a synthetic heptapeptide derivative of ACTH(4-10). Explores brain-derived neurotrophic factor elevation, enzymatic cleavage protection, and high-throughput chromatographic separation.
Read Research Report →
Exploring SS-31 (Elamipretide), a mitochondria-targeting tetrapeptide engineered to bind cardiolipin in the inner mitochondrial membrane. Examines bioenergetic support and manufacturing protocols.
Read Research Report →Clear answers to common questions regarding contract manufacturing, chemical specifications, quality assurance, and global logistics for OEM Selank 10mg.
Explore our broader catalogue of custom intermediates, specialized chemical building blocks, and bioactive formulations.
